Cite
Žukauskas M, Grybaitė B, Jonutė P, et al. Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models. Bioorg Chem. 2021;115:105214doi: 10.1016/j.bioorg.2021.105214.
Žukauskas, M., Grybaitė, B., Jonutė, P., Vaickelionienė, R., Gibieža, P., Vaickelionis, G., Dragūnaitė, B., Anusevičius, K., Mickevičius, V., & Petrikaitė, V. (2021). Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models. Bioorganic chemistry, 115105214. https://doi.org/10.1016/j.bioorg.2021.105214
Žukauskas, Mindaugas, et al. "Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models." Bioorganic chemistry vol. 115 (2021): 105214. doi: https://doi.org/10.1016/j.bioorg.2021.105214
Žukauskas M, Grybaitė B, Jonutė P, Vaickelionienė R, Gibieža P, Vaickelionis G, Dragūnaitė B, Anusevičius K, Mickevičius V, Petrikaitė V. Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models. Bioorg Chem. 2021 Oct;115:105214. doi: 10.1016/j.bioorg.2021.105214. Epub 2021 Aug 09. PMID: 34426161.
Copy
Download .nbib